Chemoinformaics analysis of (Z)-Methyl jasmonate
| Molecular Weight | 210.273 | nRot | 4 |
| Heavy Atom Molecular Weight | 192.129 | nRig | 0 |
| Exact Molecular Weight | 210.126 | nRing | 1 |
| Solubility: LogS | -7.246 | nHRing | 0 |
| Solubility: LogP | 11.028 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 34.4483 |
| nHD | 0 | BPOL | 21.5297 |
| QED | 0.161 |
| Synth | 1.718 |
| Natural Product Likeliness | 0.454 |
| NR-PPAR-gamma | 0.2 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.829 |
| HIA | 0.004 |
| CACO-2 | -5.097 |
| MDCK | 0.00000675 |
| BBB | 0.006 |
| PPB | 0.985117 |
| VDSS | 3.194 |
| FU | 0.0107005 |
| CYP1A2-inh | 0.051 |
| CYP1A2-sub | 0.148 |
| CYP2c19-inh | 0.126 |
| CYP2c19-sub | 0.051 |
| CYP2c9-inh | 0.032 |
| CYP2c9-sub | 0.975 |
| CYP2d6-inh | 0.105 |
| CYP2d6-sub | 0.021 |
| CYP3a4-inh | 0.159 |
| CYP3a4-sub | 0.017 |
| CL | 5.146 |
| T12 | 0.02 |
| hERG | 0.553 |
| Ames | 0.004 |
| ROA | 0.009 |
| SkinSen | 0.968 |
| Carcinogencity | 0.017 |
| EI | 0.926 |
| Respiratory | 0.303 |
| NR-Aromatase | 0.099 |
| Antiviral | No |
| Prediction | 0.571561 |